Tech Center 1600 • Art Units: 1657
This examiner grants 31% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17115183 | METHOD FOR DETECTING HEAVY METAL POLLUTANTS USING A FLUORESCENT MATERIAL FROM BACILLUS ENDOPHYTICUS AND METHOD FOR MAKING | Final Rejection | Imam Abdulrahman Bin Faisal University |
| 17862766 | COMPOSITION WITH LACTOBACILLUS PARACASEI AND A METHOD TO TREAT NASOPHARYNGEAL CARCINOMA THROUGH PYROPTOSIS OR CELL CYCLE ARREST | Final Rejection | GenMont Biotech Incorporation |
| 17836068 | SEAWEED-BASED POWDER | Non-Final OA | Cargill, Incorporated |
| 16982368 | SEAWEED-BASED POWDER | Non-Final OA | Cargill, Incorporated |
| 17258522 | AKKERMANSIA MUCINIPHILA EB-AMDK19 STRAIN AND USE THEREOF | Non-Final OA | ENTEROBIOME INC. |
| 18017037 | PROBIOTIC COMPOSITIONS AND THEIR USE TO MODULATE IMMUNE SYSTEMS | Final Rejection | SYNBALANCE SRL |
| 18581744 | WELLBEING SUPPLEMENT FOR POSTPARTUM MATERNAL NUTRITION | Non-Final OA | Mead Johnson Nutrition Company |
| 18027889 | NOVEL LACTIC ACID BACTERIA AND USE THEREOF | Final Rejection | NVP Healthcare Co., Ltd. |
| 17251297 | METHOD FOR DETECTING AND/OR IDENTIFYING AT LEAST ONE TARGET MICROORGANISM PRESENT ON A SURFACE | Non-Final OA | BIOMÉRIEUX |
| 18009966 | Cognitive Function Improving Agent, Cognitive Function Maintaining Agent, Hippocampus Function Improving Agent, and Hippocampus Function Maintaining Agent | Non-Final OA | MORINAGA MILK INDUSTRY CO., LTD. |
| 18041369 | FAECALIBACTERIUM PRAUSNITZII STRAIN AND USES THERE OF | Final Rejection | KOBIOLABS, INC. |
| 17765972 | Lactobacillus Acidophilus KBL409 Strain and Use Thereof | Final Rejection | KoBioLabs, Inc. |
| 18041023 | TECHNIQUE FOR QUANTITATIVE DETECTION OF BETA-GALACTOSIDASE (BETA-GAL) IN SEAWATER BASED ON SURFACE-ENHANCED RAMAN SPECTROSCOPY (SERS) | Final Rejection | SHANGHAI OCEAN UNIVERSITY |
| 17872540 | METHOD FOR ANALYZING ILEOSTOMY SUBJECTS USING A PROBIOTIC CONTAINING BACILLUS SUBTILIS | Non-Final OA | ADM Cork H&W Limited |
| 17728965 | POLYSACCHARIDE-PEPTIDE COMPLEX FOR LOWERING BLOOD SUGAR, BLOOD LIPID AND GLYCOSYLATED HEMOGLOBIN LEVELS, AND PREPARATION METHOD | Final Rejection | Jingren HE |
| 15773054 | SAMHD1 MODULATION FOR TREATING RESISTANCE TO CANCER THERAPY | Final Rejection | Johann Wolfgang Goethe-Universität Frankfurt am Main |
| 17555570 | NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES | Final Rejection | Paul Stenmark |
| 17611992 | METHOD FOR IMPROVING PRODUCTION OF STREPTOMYCES POLYKETIDE COMPOUNDS | Non-Final OA | INSTITUTE OF MICROBIOLOGY, CHINESE ACADEMY OF SCIENCES |
| 16895641 | ACTIVATED BIFIDOBACTERIA AND METHODS OF USE THEREOF | Non-Final OA | INFINANT HEALTH, INC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy